Evidence map›Paper›PMID 40254166›Full record

ArticleAnalytical biochemistry2025

Isolation and functional properties of highly-purified N-terminal domain of human NaPi2b by scalable "resin overload" technique.

Daria Savenkova, Irina Makarenko, Daria Nedorezova, Ramziya Kiyamova, Mikhail Bogdanov

Abstract read
In one paragraph

Article in Analytical biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daria SavenkovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Irina MakarenkoResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation; Department of Biology, University of Padua, Padua, Italy.
Daria NedorezovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Ramziya KiyamovaResearch Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
Mikhail BogdanovDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center, McGovern Medical School, Houston, TX, 77030, USA. Electronic address: mikhail.v.bogdanov@uth.tmc.edu.

Funding

Protein sequence determinants and properties of the lipid bilayer that govern membrane protein dynamic organizationR01GM121493 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOGDANOV, MIKHAIL V., DOWHAN, WILLIAM · 2017 to 2025
$3.6M
NIGMS NIH HHS R01 GM121493
6 · The paper itself

Abstract

Despite the enthusiasm and advances in the purification of native and engineered full-length membrane proteins, little attention has been paid to their fragments which could serve as attractive inspiration for function, regulation, or targeting of full-length membrane protein with therapeutic antibodies (Abs). Production of recombinant fragments of "therapeutic" membrane proteins for early-stage discovery research requires their purification to near homogeneity. It is important not only for the production of biotherapeutic antibodies but also for structural and functional studies of competitive protein-Abs, protein-protein, and lipid-protein interactions which heavily rely on the purity and quality of the isolated protein fragment of interest. The development of novel strategies for simple but still highly efficient protein purification remains a one of main research focus in the biotechnology and biomedicine because conventional purification approaches require complex manipulation steps and are timely and costly. Here, we would like to introduce a simple and rapid protein purification strategy for the human NaPi2b N-terminal (NT) sequence recombinantly expressed in a bacterial host at a laboratory scale. We demonstrate that "resin overload" e.g. the conditions when loading exceeds dynamic binding capacity can be counterintuitively but intelligently utilized to isolate highly purified protein fragments and prevent non-specific low-affinity binding of contaminant endogenous host proteins. The results showed that this method allowed us to achieve the highest purity while maintaining both immunogenic (recognition by Abs) and functional (phosphorylation) properties of the NaPi2b NT sequence. Although adaptations are required on a case-to-case basis, we believe this work can inspire other researchers working with the purification of protein and protein fragments to apply this proof-of-principle in a scalable manner.

Indexed as

Chromatography, AffinityEscherichia coliHumansProtein DomainsRecombinant ProteinsRecombinant ProteinsMembrane proteinNaPi2bN-terminal domainsPeptidePurification

Identifiers

PMID40254166
PMCPMC12077926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.